PATIENT PREFERENCES: UNDERSTANDING RISK-BENEFIT TRADE-OFFS OF GENOMIC TESTING IN CHEMOTHERAPY DECISIONS FOR BREAST CANCER PATIENTS

被引：1
|
作者：
Marshall, D. [1 ,2 ]
Bombard, Y. [3 ]
Trudeau, M. [4 ]
Leighl, N. [5 ]
Pykerman, K. [6 ]
Deal, K. [7 ]
机构：
[1] Univ Calgary, Fac Med, Alberta Bone & Joint Hlth Inst, Calgary, AB, Canada
[2] Optuminsight, Calgary, AB, Canada
[3] Yale Univ, New Haven, CT USA
[4] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[5] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[6] Univ Calgary, Calgary, AB, Canada
[7] McMaster Univ, Hamilton, ON, Canada
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.724
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A147 / A148
页数：2
相关论文
共 50 条
  • [41] A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer
    Stover, Daniel
    Veney, Deloris
    Hampel, Heather
    Toland, Amanda E.
    Presley, Carolyn
    Padamsee, Tasleem
    Lee, Clara
    Hovick, Shelly
    Senter, Leigha
    CANCER RESEARCH, 2023, 83 (05)
  • [42] THE VALUE OF PERSONALIZING MEDICINE: MEDICAL ONCOLOGISTS' AND PATIENTS' PERSPECTIVES ON GENOMIC TESTING OF BREAST TUMOURS IN CHEMOTHERAPY TREATMENT DECISIONS
    Marshall, D. A.
    Bombard, Y.
    Rozmovits, L.
    Trudeau, M.
    Leighl, N.
    Deal, K.
    VALUE IN HEALTH, 2012, 15 (07) : A429 - A429
  • [43] The value of personalizing medicine: Medical oncologists' and patients' perspectives on genomic testing of breast tumors in chemotherapy treatment decisions
    Trudeau, Maureen E.
    Bombard, Yvonne
    Rozmovits, Linda
    Leighl, Natasha B.
    Deal, Ken
    Marshall, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
    Emily A Burger
    Kine Pedersen
    Stephen Sy
    Ivar Sønbø Kristiansen
    Jane J Kim
    British Journal of Cancer, 2017, 117 : 783 - 790
  • [45] Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
    Burger, Emily A.
    Pedersen, Kine
    Sy, Stephen
    Kristiansen, Ivar Sonbo
    Kim, Jane J.
    BRITISH JOURNAL OF CANCER, 2017, 117 (06) : 783 - 790
  • [46] Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study
    Wang, Limin
    Liu, Shimeng
    Jiang, Shan
    Li, Chaofan
    Lu, Liyong
    Fang, Yunhai
    Li, Shunping
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [47] What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment
    Alten, Rieke
    Nieto-Gonzalez, Juan Carlos
    Jacques, Peggy
    Montecucco, Carlomaurizio
    Moots, Robert
    Radner, Helga
    Vonkeman, Harald E.
    Heidenreich, Sebastian
    Whichello, Chiara
    Krucien, Nicolas
    Van Beneden, Katrien
    RMD OPEN, 2024, 10 (01):
  • [48] Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with 'Intermediate' Risk of Mortality at 10 Years
    Alrifai, D.
    Harper-Wynne, C.
    Jyothirmayi, R.
    Burcombe, R.
    CLINICAL ONCOLOGY, 2016, 28 (05) : E1 - E1
  • [49] Understanding how breast cancer patients use risk information from genomic tests
    DeFrank, Jessica T.
    Carey, Lisa A.
    Brewer, Noel T.
    JOURNAL OF BEHAVIORAL MEDICINE, 2013, 36 (06) : 567 - 573
  • [50] Evaluating the Consistency of Patient Preference Estimates: Systematic Variation in Survival—Adverse Event Trade-Offs in Patients with Cancer or Cardiovascular Disease
    Kevin Marsh
    Nicolas Krucien
    The Patient - Patient-Centered Outcomes Research, 2022, 15 : 69 - 75
12345